We hypothesized that up-regulation of DNA damage response genes such as ERH, ATR and CHK1 in HCC tumor cells could contribute toward resistance to DNA-damaging chemotherapy and inhibiting DNA damage response might thus overcome this resistance. The gene discussed is CHEK1; the disease is neoplasm.